联系人：李经理
手机：18116171568
邮箱：lgj@theramabs.com
地址：上海浦东新区惠南镇东征路133号
网址：www.Theraprotein.com
Product Name：Rituximab |
Introduction: |
This product is the biosimilar of Rituximab (174722-31-7), which is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. The biosimilar has an approximate molecular weight of 145 kDa, which is produced by mammalian cell (Chinese Hamster Ovary) suspension culture in a nutrient medium. *Statement: this product is used for R&D and IND only, not for clinical and commercial usage before registered in drug registration authority. |
Features and Advantages: |
| NameRituximabCAS NO.174722-31-7TypeWhole antibodySourceChimeric(mouse/human)TargetCD20CloneMonocloneFormulaC6416H9874N1688O1987S44Molecular Weight145 kDaAntibody FormPurified immunoglobulinPhysical FormSolution Place of OriginUSAStorageSealed and stored at -70±15℃, away from light |
Specifications: |
The Rituximab is supplied at 2mg/tube, 5mg/tube, 10mg/tube, 20mg/tube as a sterile, clear and colorless, preservative-free solution. |
Quality Assurance： |
(1) We have advanced technology and equipment to satisfy the requirements of GMP. All the raw material purchasing and production quality control are strictly following the ISO9001. (2) We own a group of QCs with rich experience, mainly engaging in testing APIs, intermediates and finished products. Before posting, all of the stuffs must receive professional training and GMP courses. (3) The COA(Certificate of Analysis), MOA(Method of Analysis), SDS(Stability Data Sheet), DMF(Drug Master File) and MSDS(Material Safety Data Sheet) are available. |